Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220017333 220017803 1.56 82 Curative (C) 2017-03-25 2017-04-16 Alemtuz+Fludara+Melphalan RIC MUD N N 220030085 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017334 220007822 0 69.7 Curative (C) 2018-04-09 2018-04-11 Dasatinib 02 N 220030087 DASATINIB
220017335 220017804 null 81.1 Curative (C) 2017-04-17 2017-04-26 AML 18 TRIAL N N 220030089 AML18 TRIAL
220017336 220014305 1.86 80 Curative (C) 2017-03-27 2017-03-28 AML 18 TRIAL 01 N 220030092 AML18 TRIAL
220017337 220014305 1.59 62 null 2016-06-23 2016-06-28 AML 18 TRIAL Y N 220030092 AML18 TRIAL
220017338 220007824 1.72 90 Curative (C) 2013-10-09 2013-10-18 Alemtuz+Fludara+Melphalan RIC MUD N N 220030093 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017339 220014307 1.5 0 Curative (C) 2017-08-18 2017-11-07 Rituximab N N 220030106 RITUXIMAB
220017340 220014308 1.85 96.6 Curative (C) null 2014-03-15 Alemtuz+Fludara+Melphalan RIC MUD Y N 220030109 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017341 220014309 0 80 Curative (C) 2015-12-12 2015-12-12 Alemtuz+Fludara+Melphalan RIC MUD 2 N 220030109 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017342 220007830 1.85 72 Disease modification (D) 2015-11-03 2015-11-09 ALEMTUZUMAB + FLUDARABINE + MELPHALAN 02 N 220030114 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017343 220021891 1.71 42.35 Curative (C) 2018-10-05 2019-02-13 Dasatinib N N 220030117 DASATINIB
220017344 220021891 1.7 42.35 Curative (C) 2019-03-06 2019-03-06 Dasatinib 2 N 220030117 DASATINIB
220017345 220014311 1.6 93 Disease modification (D) 2013-10-12 2014-03-07 AML18 PILOT TRIAL 1 N 220030138 PILOT TRIAL
220017346 220014313 1.67 null Adjuvant (A) 2017-12-05 2017-12-19 Dasatinib N N 220030141 DASATINIB
220017347 220007835 1.96 null Curative (C) 2015-07-11 2015-08-23 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220030142 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017348 220007838 null 63.9 Curative (C) 2015-11-24 2015-11-24 AML18 PILOT TRIAL N null 220030144 PILOT TRIAL
220017349 220007841 1.64 72 Curative (C) null 2014-01-24 AML 18 TRIAL 01 null 220030145 AML18 TRIAL
220017350 220007844 1.67 null Curative (C) 2018-01-21 2018-02-06 Dasatinib N N 220030148 DASATINIB
220017351 220007851 1.86 89.3 Curative (C) 2019-01-24 2019-01-24 ALEMTUZUMAB + FLUDARABINE + MELPHALAN 02 N 220030168 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017352 220007853 1.5 66.4 Palliative (P) 2015-07-29 2015-07-29 AML 18 TRIAL Y N 220030168 AML18 TRIAL
220017353 220007854 1.71 64.8 Curative (C) 2014-12-02 2014-12-02 Alemtuz+Fludara+Melphalan RIC MUD 2 N 220030179 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017354 220007856 1.56 68.9 Neo-adjuvant (N) 2016-10-12 2016-10-19 Dasatinib N N 220030182 DASATINIB
220017355 220007860 1.72 null Curative (C) 2015-01-20 2017-12-25 Rituximab N N 220030188 RITUXIMAB
220017356 220007864 0 63.5 Curative (C) 2017-07-30 2017-08-05 Dasatinib 1 null 220030191 DASATINIB
220017357 220007870 1.78 109 Curative (C) 2013-07-20 2013-07-26 Alemtuz+Fludara+Melphalan RIC MUD N N 220030214 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017358 220007873 1.76 77.7 Curative (C) 2017-03-31 2017-03-31 Alemtuz+Fludara+Melphalan RIC MUD N N 220030225 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017359 220007877 1.65 108 Curative (C) 2017-09-28 2017-10-01 AML 18 TRIAL N N 220030228 AML18 TRIAL
220017360 220007878 1.78 77.5 Curative (C) 2016-10-31 2017-02-04 AML 18 TRIAL Y N 220030233 AML18 TRIAL
220017361 220007883 null 115 Disease modification (D) 2013-05-08 2013-05-12 Dasatinib 2 null 220030238 DASATINIB
220017362 220007884 null 76.9 Curative (C) 2014-01-09 2015-11-25 Dasatinib N null 220030250 DASATINIB
220017365 220007892 1.57 40.3 Curative (C) 2017-04-26 2017-04-26 Alemtuz+Fludara+Melphalan RIC MUD N null 220030275 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017366 220007895 1.71 77 Curative (C) 2017-12-19 2017-12-19 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N null 220030276 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017367 220007897 1.85 80.9 Disease modification (D) 2013-10-22 2014-01-22 AML18 PILOT TRIAL 1 N 220030281 PILOT TRIAL
220017368 220007899 0 73.6 Curative (C) 2013-09-18 2013-09-25 Rituximab 02 N 220030289 RITUXIMAB
220017369 220007901 1.64 68.4 Disease modification (D) 2014-09-05 2014-09-13 AML 18 TRIAL Y N 220030292 AML18 TRIAL
220017370 220007902 1.93 65.2 Disease modification (D) 2016-06-20 2016-06-20 Alemtuz+Fludara+Melphalan RIC MUD 02 N 220030293 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017371 220014336 1.6 72.2 Disease modification (D) 2014-10-08 2014-10-13 Alemtuz+Fludara+Melphalan RIC MUD N N 220030293 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017372 220007905 1.66 51.5 Curative (C) 2016-12-06 2017-04-02 AML18 PILOT TRIAL Y N 220030299 PILOT TRIAL
220017373 220007908 1.62 71.45 Palliative (P) 2014-05-31 2014-06-01 AML 18 TRIAL Y N 220030302 AML18 TRIAL
220017374 220014341 1.8 104 Disease modification (D) 2017-02-27 2017-03-02 AML18 PILOT TRIAL null null 220030310 PILOT TRIAL
220017375 220014344 1.66 101.5 Curative (C) 2015-03-19 2015-03-19 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220030316 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017376 220014345 1.7 52 Curative (C) 2017-07-26 2017-08-01 Alemtuz+Fludara+Melphalan RIC MUD N N 220030318 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017377 220019778 0 77.7 Disease modification (D) 2015-04-21 2015-04-21 Alemtuz+Fludara+Melphalan RIC MUD N N 220030337 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017378 220007926 1.6 66.8 Curative (C) 2013-12-15 2013-12-27 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220030339 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017379 220007927 null 27.5 Disease modification (D) 2016-02-25 2016-04-28 Rituximab N N 220030348 RITUXIMAB
220017380 220007928 1.6 57.2 Curative (C) 2013-11-23 2013-11-23 Alemtuz+Fludara+Melphalan RIC MUD N N 220030353 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220017381 220014350 1.7 72 Curative (C) 2014-06-22 2014-06-27 Rituximab N N 220030353 RITUXIMAB
220017382 220007933 1.74 0 Curative (C) 2013-08-13 2015-01-30 Dasatinib null N 220030366 DASATINIB
220017383 220007936 1.8 0 Curative (C) 2015-01-31 2015-01-31 Dasatinib Y N 220030379 DASATINIB
220017384 220007936 1.83 99 Palliative (P) 2014-11-14 2015-01-07 AML18 PILOT TRIAL N N 220030379 PILOT TRIAL